Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

NCT00306124 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Mild Cognitive Impairment
Healthy

Interventions

DRUG: Levodopa

Sponsor

University Hospital Muenster